Q4 2019 13F Holders as of 12/31/2019
-
Type / Class
-
Equity / NY ARCA BIOTECH
-
Number of holders
-
205
-
Total shares
-
5.48M
-
Shares change
-
-540K
-
Total reported value, excl. options
-
$816M
-
Value change
-
-$74.7M
-
Put/Call ratio
-
0.55
-
Number of buys
-
77
-
Number of sells
-
-95
-
Price
-
$148.72
Significant Holders of FIRST TR EXCHANGE-TRADED FD - NY ARCA BIOTECH (FBT) as of Q4 2019
202 filings reported holding FBT - FIRST TR EXCHANGE-TRADED FD - NY ARCA BIOTECH as of Q4 2019.
FIRST TR EXCHANGE-TRADED FD - NY ARCA BIOTECH (FBT) has 205 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 5.48M shares
.
Largest 10 shareholders include MORGAN STANLEY (822K shares), WELLS FARGO & COMPANY/MN (770K shares), BANK OF AMERICA CORP /DE/ (766K shares), UBS Group AG (392K shares), ROYAL BANK OF CANADA (254K shares), Raymond James Financial Services Advisors, Inc. (248K shares), AMERIPRISE FINANCIAL INC (203K shares), LPL Financial LLC (189K shares), RAYMOND JAMES & ASSOCIATES (163K shares), and MILLENNIUM MANAGEMENT LLC (144K shares).
This table shows the top 205 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.